Sector News

Lonza buys InterHealth in health push

August 15, 2016
Chemical Value Chain

Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.

Lonza said the California company’s range of products like UC-11 to promote healthy joints would complement its own in sports nutrition, weight management, immune and pet health.

“With this acquisition Lonza is taking a further step along our strategic path as a high-value supplier to the healthcare continuum,” Chief Executive Richard Ridinger said in a statement, adding that the deal also boosted Lonza’s offerings in cognitive and diabetes health.

The consultancy KPMG has forecast that the nutraceuticals market will be worth $280 billion in 2018, a factor that it expects will prompt a wave of mergers and acquisitions.

Swiss food giant Nestle is among companies that have shown an increasing interest in health foods, hiring a new CEO from German medical company Fresenius and investing in firms whose products are meant to restore a healthy bacterial balance in the gut.

GLOBAL ROLLOUT

Ridinger said Lonza would sell Interhealth’s products globally and use the U.S. company’s network to distribute the Swiss firm’s existing product range.

“Lonza has succeeded in making an important step in expanding its product portfolio into the attractive area of nutritional ingredients,” said Zuercher Kantonalbank analyst Philipp Gamper. “This area promises above average growth and good margins with less cyclical volatility.”

The Swiss company, which also makes products like drinking water sanitizers and preservatives for industrial applications, currently generates nearly 42 percent of its sales from pharmaceutical and biotech products.

But the nutraceuticals area is faster growing and more profitable than Lonza’s specialty ingredients business, which makes ingredients that go into consumer care products.

By John Revill

Source: Reuters

comments closed

Related News

October 1, 2023

INEOS announces the acquisition of the Eastman Texas City Site for ~$500 million

Chemical Value Chain

The deal includes the 600kt Acetic Acid plant and all associated third party activities on the site. Eastman and INEOS have also entered into a Memorandum of Understanding to explore options for a long-term supply agreement for vinyl acetate monomer.

October 1, 2023

Executive Vice President Lucrèce Foufopoulos-De Ridder to leave Borealis

Chemical Value Chain

The Supervisory Board of Borealis has accepted the decision of Lucrèce Foufopoulos-De Ridder, EVP Polyolefins, Circular Economy Solutions and Innovation & Technology to step down from her executive position at Borealis, and the Board of Borouge Pte effective 31 December 2023 to pursue other career opportunities.

October 1, 2023

Sidel unveils new StarLiteR rPET solution

Chemical Value Chain

Sidel has launched a new 100% rPET bottle base, StarLiteR, aiming to help carbonated soft drink (CSD) packaging producers embrace material circularity. StarLiteR allows CDS producers to switch to rPET bottle production easily and efficiently, while significantly reducing the impact on product quality or packaging integrity.

How can we help you?

We're easy to reach